Over the past several years, biomedical researchers and scientists from Europe and China have been holding workshops and collaborating on a project to establish an ethical framework for clinical trials and biomedical research conducted across cultures—namely, as a result of partnerships between European and Chinese life science companies.
Pfizer has decided to drop two late-stage drug candidates because, according to this AP story, it sees no real market potential for them. That is, it sees no blockbuster potential. And, as the article implies, this is in direct response to the Wyeth purchase and the fact that the company...
A new report conducted by doctors at the University of California-San Francisco claims that pharmaceutical companies are still not being transparent in the reporting of their clinical trials, finding that some are up to five times more likely to report positive findings than negative.
Janet Woodcock, head of FDA’s CDER, strikes me as the type of person you’d want in charge during a crisis. And that’s exactly where FDA, and CDER, have found themselves this year, so I’m not surprised that Dr. W.
Yesterday's announcement that Eli Lilly had sold off its Greenfield, Indiana, R&D facility to Covance is perhaps not just a big deal, but really a bellwether move that may signal a trend of Big Pharma companies not just outsourcing aspects of their R&D operations but selling them off altogether.
George Laszlo has been keeping tabs on the technology offerings in his blog. For access to this very handy list, a work-in-progress, read on. Also note posts on open-source code (technology is ready, but is the industry ready for it, he asks) and the changing role of the Pharma CIO.
A storm, complete with hail, thunder and generous amounts of lightning, appeared to follow me through Connecticut and Rhode Island as I drove to Boston on Wednesday for the DIA meeting. Didn't make it until almost 4 PM, only to have the storm break out in Boston at 6 PM...
Have been away from the epicenter of political corruption for a while. New York is quite a bit tamer on that score than Chicago. Not so its tabloid headline writing (especially at the New York Post), which is as brilliant as it is uncivilized.
Am starting to feel like the witch in "The Wiz" -- "Don't nobody bring me no bad news." A quick look at some headlines brought yet another story of blockbuster-challenged pharma ethics, this time involving Germany's Bayer AG.